AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD. - Rabe KF; Martinez FJ; Bhatt SP; Kawayama T; Cosio BG; Mroz RM; Boomsma MM; Goulaouic H; Nivens MC; Djandji M; Soler X; Liu Y; et al. (ERJ open research, 2024)